Similar Articles
The Use of Clobazam as Add-on Treatment in Resistant Epilepsy: Our Retrospective Clinical Data
Damla Çetinkaya, Seher Naz Yeni
DOI: 10.4274/tnd.2019.22755
Issue: 2020, Volume 26 - Issue 1
0
341
Quality of Life in Patients with Drug Resistant Epilepsy
Hari Krishan Aggarwal, Deepak Jain, Avina Bishnoi
DOI: 10.4274/tnd.2019.31391
Issue: 2019, Volume 25 - Issue 3
0
474
The Effect of Ketogenic Diet Treatment in Drug-resistant Epilepsies of Childhood
Gizem Özata Uyar, Nevin Şanlıer
DOI: 10.4274/tnd.71473
Issue: 2018, Volume 24 - Issue 3
0
303
Lamotrigine; A New Drug for the Treatment of Glossopharyngeal Neuralgia? A Case Report
Egemen VARDARLI, Safiye BİLGİN, Zafer ÇOLAKOĞLU, Burhanettin ULUDAĞ
Issue: 1996, Volume 2 - Issue 3-4
0
219
Urbach-Wiethe Disease and Intractable Epilepsy
Betül BAYKAN KURT, Ayşen GÖKYİĞİT, Oğuzhan ÇOBAN, Esen ÖZKAYA, Güzin ÖZARMAĞAN
Issue: 1995, Volume 1 - Issue 2
0
148
Pandemic-Triggered Aberrant Drug Use may Cause Failure of Antiepileptic Therapy
Manolya Bergüzar Şekerlisoy, Aslıhan Taşkıran Sağ
DOI: 10.4274/tnd.2021.45804
Issue: 2021, Volume 27 - Supplement 1
0
246